ACLARIS THERAPEUTICS INC's ticker is ACRS and the CUSIP is 00461U105. A total of 59 filers reported holding ACLARIS THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $9,768,000 | +148.2% | 1,509,812 | -1.4% | 0.52% | +86.8% |
| Q3 2020 | $3,935,000 | +58.6% | 1,531,312 | 0.0% | 0.28% | +53.6% |
| Q2 2020 | $2,481,000 | +14.3% | 1,531,312 | -26.6% | 0.18% | -19.4% |
| Q1 2020 | $2,171,000 | -45.0% | 2,087,312 | 0.0% | 0.23% | -36.2% |
| Q4 2019 | $3,945,000 | -13.0% | 2,087,312 | +240.1% | 0.36% | -21.6% |
| Q4 2018 | $4,535,000 | +192.8% | 613,728 | +922.9% | 0.45% | +120.4% |
| Q3 2017 | $1,549,000 | -69.2% | 60,000 | -67.7% | 0.21% | -76.9% |
| Q2 2017 | $5,030,000 | -74.9% | 185,472 | -72.4% | 0.89% | -82.4% |
| Q1 2017 | $20,072,000 | +78.6% | 673,100 | +62.6% | 5.07% | +41.9% |
| Q4 2016 | $11,236,000 | – | 414,000 | – | 3.58% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management V, LLC | 1,258,243 | $8,618,965 | 13.75% |
| Foresite Capital Management IV, LLC | 2,808,034 | $19,235,033 | 10.68% |
| Bain Capital Life Sciences Investors, LLC | 3,400,000 | $23,290,000 | 2.60% |
| GREAT POINT PARTNERS LLC | 1,691,768 | $11,588,611 | 2.11% |
| Samsara BioCapital, LLC | 696,171 | $4,768,771 | 1.46% |
| Altium Capital Management LP | 403,000 | $2,760,550 | 1.44% |
| BVF INC/IL | 7,064,736 | $48,393,442 | 1.30% |
| Aisling Capital Management LP | 434,455 | $2,976,017 | 1.23% |
| GREAT POINT PARTNERS LLC | 700,000 | $4,795,000 | 0.87% |
| VR Adviser, LLC | 1,040,754 | $7,129,165 | 0.75% |